These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 30914374)

  • 1. Conjugation of staphylokinase with the arabinogalactan-PEG conjugate: Study on the immunogenicity, in vitro bioactivity and pharmacokinetics.
    Qi F; Qi J; Hu C; Shen L; Yu W; Hu T
    Int J Biol Macromol; 2019 Jun; 131():896-904. PubMed ID: 30914374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conjugation with Eight-Arm PEG Markedly Improves the In Vitro Activity and Prolongs the Blood Circulation of Staphylokinase.
    Qi F; Hu C; Yu W; Hu T
    Bioconjug Chem; 2018 Feb; 29(2):451-458. PubMed ID: 29298046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-based antigenic epitope and PEGylation improve the efficacy of staphylokinase.
    Xu Y; Shi Y; Zhou J; Yang W; Bai L; Wang S; Jin X; Niu Q; Huang A; Wang D
    Microb Cell Fact; 2017 Nov; 16(1):197. PubMed ID: 29137636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of site-specific PEGylation on the fibrinolytic activity, immunogenicity, and pharmacokinetics of staphylokinase.
    Liu J; Wang Z; He J; Wang G; Zhang R; Zhao B
    Acta Biochim Biophys Sin (Shanghai); 2014 Sep; 46(9):782-91. PubMed ID: 25098624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenyl linker-induced dense PEG conformation improves the efficacy of C-terminally monoPEGylated staphylokinase.
    Xue X; Li D; Yu J; Ma G; Su Z; Hu T
    Biomacromolecules; 2013 Feb; 14(2):331-41. PubMed ID: 23301655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular insight into the steric shielding effect of PEG on the conjugated staphylokinase: biochemical characterization and molecular dynamics simulation.
    Mu Q; Hu T; Yu J
    PLoS One; 2013; 8(7):e68559. PubMed ID: 23874671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetic and stoichiometric analysis of the modification process for N-terminal PEGylation of staphylokinase.
    Wang J; Hu T; Liu Y; Zhang G; Ma G; Su Z
    Anal Biochem; 2011 May; 412(1):114-6. PubMed ID: 21185800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenyl amide linker improves the pharmacokinetics and pharmacodynamics of N-terminally mono-PEGylated human growth hormone.
    Wu L; Ji S; Shen L; Hu T
    Mol Pharm; 2014 Sep; 11(9):3080-9. PubMed ID: 25115329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction of a novel Staphylokinase (SAK) mutant with low immunogenicity and its evaluation in rhesus monkey.
    Wang M; Chen Y; Fu W; Zou M; Wang Y; Xing W; Wang J; Xu D
    Int J Biol Macromol; 2020 Mar; 146():781-789. PubMed ID: 31730959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poly(ethylene glycol)-radix Ophiopogonis polysaccharide conjugates: preparation, characterization, pharmacokinetics and in vitro bioactivity.
    Lin X; Wang S; Jiang Y; Wang ZJ; Sun GL; Xu DS; Feng Y; Shen L
    Eur J Pharm Biopharm; 2010 Oct; 76(2):230-7. PubMed ID: 20633648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A solid-phase adsorption method for PEGylation of human serum albumin and staphylokinase: preparation, purification and biochemical characterization.
    Suo X; Lu X; Hu T; Ma G; Su Z
    Biotechnol Lett; 2009 Aug; 31(8):1191-6. PubMed ID: 19343505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-Terminal Modification with Pseudo-Bifunctional PEG-Hexadecane Markedly Improves the Pharmacological Profile of Human Growth Hormone.
    Wu L; Ji S; Hu T
    Mol Pharm; 2015 May; 12(5):1402-11. PubMed ID: 25849255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous elimination of T- and B-cell epitope by structure-based mutagenesis of single Glu80 residue within recombinant staphylokinase.
    He J; Xu R; Chen X; Jia K; Zhou X; Zhu K
    Acta Biochim Biophys Sin (Shanghai); 2010 Mar; 42(3):209-15. PubMed ID: 20213046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical development of PEGylated recombinant staphylokinase (PEG-Sak) for bolus thrombolytic treatment of patients with acute myocardial infarction.
    Moreadith RW; Collen D
    Adv Drug Deliv Rev; 2003 Sep; 55(10):1337-45. PubMed ID: 14499711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Readily adaptable release kinetics of prodrugs using protease-dependent reversible PEGylation.
    Böttger R; Knappe D; Hoffmann R
    J Control Release; 2016 May; 230():88-94. PubMed ID: 27067364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High resolution mapping of the B cell epitopes of staphylokinase in humans using negative selection of a phage-displayed antigen library.
    Jenné S; Brepoels K; Collen D; Jespers L
    J Immunol; 1998 Sep; 161(6):3161-8. PubMed ID: 9743384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal structure of a staphylokinase: variant a model for reduced antigenicity.
    Chen Y; Song G; Jiang F; Feng L; Zhang X; Ding Y; Bartlam M; Yang A; Ma X; Ye S; Liu Y; Tang H; Song H; Rao Z
    Eur J Biochem; 2002 Jan; 269(2):705-11. PubMed ID: 11856331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potent Antigen-Adjuvant Delivery System by Conjugation of Mycobacterium tuberculosis Ag85B-HspX Fusion Protein with Arabinogalactan-Poly(I:C) Conjugate.
    Huang Q; Yu W; Hu T
    Bioconjug Chem; 2016 Apr; 27(4):1165-74. PubMed ID: 27002920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid modification of staphylokinase and its implications on stability and activity.
    Mannully ST; Shanthi C; Pulicherla KK
    Int J Biol Macromol; 2019 Jan; 121():1037-1045. PubMed ID: 30342946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PEGylated recombinant human interferon-ω as a long-acting antiviral agent: structure, antiviral activity and pharmacokinetics.
    Yu W; Yu C; Wu L; Fang T; Qiu R; Zhang J; Yu T; Fu L; Chen W; Hu T
    Antiviral Res; 2014 Aug; 108():142-7. PubMed ID: 24936771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.